THE SIGNAL is a curated Web3 service marketplace connecting founders with verified partners including market makers, VCs, security auditors, infrastructure providers, and tooling services through warm introductions.

How does THE SIGNAL work for Web3 founders?

Browse the directory to discover vetted Web3 partners by category (market making, VC, security, infrastructure). Click on any partner to view their profile and request a warm introduction via Telegram.

What categories of partners are available?

THE SIGNAL features market makers, venture capital firms, security auditors, infrastructure providers, blockchain analytics tools, launchpads, advisory services, and Web3 development tools.

How do warm introductions work?

Click 'Request Introduction' on any partner profile. A personalized message template will be copied to your clipboard. Paste it in Telegram to connect directly with us for a curated warm introduction.

Is THE SIGNAL free to use?

Yes, browsing THE SIGNAL and requesting introductions is completely free during the beta phase. Partners may have their own service fees.

How are partners vetted on THE SIGNAL?

All partners are manually reviewed and verified. Each has a Trust Score (88-99%) based on track record, client feedback, and industry reputation.

Can I list my service on THE SIGNAL?

Yes, submit your service via the Partner Login flow. During beta, eligible listings are reviewed for Featured placement to generate qualified inbound leads.

THE SIGNAL is a curated Web3 service marketplace connecting founders with verified partners including market makers, VCs, security auditors, infrastructure providers, and tooling services through warm introductions.

How does THE SIGNAL work for Web3 founders?

Browse the directory to discover vetted Web3 partners by category (market making, VC, security, infrastructure). Click on any partner to view their profile and request a warm introduction via Telegram.

What categories of partners are available?

THE SIGNAL features market makers, venture capital firms, security auditors, infrastructure providers, blockchain analytics tools, launchpads, advisory services, and Web3 development tools.

How do warm introductions work?

Click 'Request Introduction' on any partner profile. A personalized message template will be copied to your clipboard. Paste it in Telegram to connect directly with us for a curated warm introduction.

Is THE SIGNAL free to use?

Yes, browsing THE SIGNAL and requesting introductions is completely free during the beta phase. Partners may have their own service fees.

How are partners vetted on THE SIGNAL?

All partners are manually reviewed and verified. Each has a Trust Score (88-99%) based on track record, client feedback, and industry reputation.

Can I list my service on THE SIGNAL?

Yes, submit your service via the Partner Login flow. During beta, eligible listings are reviewed for Featured placement to generate qualified inbound leads.

Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:

The Signal TakeNeutral

Altcoins Regulation Trading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt

Share:

📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Never miss a Web3 update

Related News

Bitcoin eyes $75,000, nearing 25% bounce from February bottom

Australian Senate committee backs crypto bill requiring platforms to get licensed

Australian Senate panel backs crypto regulation framework

ShapeShift founder Erik Voorhees buys $56 million worth of Ethereum: onchain analysts

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Never miss a Web3 update

Related News

Bitcoin eyes $75,000, nearing 25% bounce from February bottom

Australian Senate committee backs crypto bill requiring platforms to get licensed

Australian Senate panel backs crypto regulation framework

ShapeShift founder Erik Voorhees buys $56 million worth of Ethereum: onchain analysts

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Never miss a Web3 update

Related News

Bitcoin eyes $75,000, nearing 25% bounce from February bottom

Australian Senate committee backs crypto bill requiring platforms to get licensed

Australian Senate panel backs crypto regulation framework

ShapeShift founder Erik Voorhees buys $56 million worth of Ethereum: onchain analysts

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Never miss a Web3 update

Related News

Bitcoin eyes $75,000, nearing 25% bounce from February bottom

Australian Senate committee backs crypto bill requiring platforms to get licensed

Australian Senate panel backs crypto regulation framework

ShapeShift founder Erik Voorhees buys $56 million worth of Ethereum: onchain analysts